Using ‘mindfulness’ to help treat anxiety and depression
Independent Nurse April 1, 2011 Suzy Bashford
NICE recommends the use of mindfulness techniques as a psychological therapy.
Depression research published in 2011
Page 2 of 2: studies 21 to 31 of 31, newest first. Back to the depression overview
Studies
Is it medication versus mindfulness in prevention of depression relapse?
Neuropsychiatry April 1, 2011 Peter Bieling 3 citations
Mindfulness-based cognitive therapy (MBCT) is still a relatively new, standalone treatment for the prevention of relapse in depression. Combining about equal parts of mindfulness (Vipassana) meditation and cognitive behavioral principles, the treatment is 8 weeks of 2 h sessions for a group of remitted participants that can range in size (8–15 would be typical).
Eficacia de los tratamientos psicológicos basados en mindfulness para los trastornos de ansiedad y depresión : una revisión sistemática = Effectiveness of mindfulness based treatments for anxiety and depressive disorders : a systematic review
Revista de Psicopatología y Psicología Clínica April 1, 2011 María Teresa Miró, Lilisbeth Perestelo-Pérez, Jeanette Pérez Ramos et al. 27 citations
The aim of this study was to determine the degree of clinical effi cacy of mindfulness based treatments in the treatment of anxiety and/or depressive disorders, from a systematic review of relevant studies in the scientifi c literature. From a total of 1,450 references identifi ed, 15 studies met the selection criteria. Systematic analysis of these studies showed that interventions based on...
[The role of the glutamatergic system in pathophysiology and pharmacotherapy for depression: preclinical and clinical data].
Fortschritte der Neurologie · Psychiatrie April 2011 Georgios Paslakis, P Gass, Michael Deuschle
An increasing significance has been attributed to the glutamatergic system in the pathophysiology of affective disorders. Glutamate is the most important excitatory neurotransmitter in the central nervous system. Glia cells are crucial regulators of the glutamatergic metabolism. Several studies have reported a dysfunction or reduced number of glia cells in patients suffering from depression....
The Effect of Meditation on Self-Reported Measures of Stress, Anxiety, Depression, and Perfectionism in a College Population
Journal of College Student Psychotherapy March 31, 2011 Jaimie L. Burns, Randolph M. Lee, Lauren J. Brown 78 citations
The effects of meditation, specifically Transcendental Meditation (TM), on college students' experience of stress, anxiety, depression, and perfectionistic thoughts was investigated using 43 undergraduate students. Self-report measures of the variables were completed prior to the start of the study. Student groups were trained in TM and practiced the technique consistently over a two-semester...
Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway.
Neuroscience March 17, 2011 H Kamiyama, M Matsumoto, S Otani et al.
The non-competitive N-methyl-D-aspartate NMDA receptor antagonist ketamine, a dissociative anesthetic capable of inducing analgesia, is known to have psychotomimetic actions, but the detailed mechanisms remain unclear because of its complex properties. The present study elucidated neural mechanisms of the effect of ketamine, at doses that exert psychotomimetic effects without anesthetic and...
Biologic effects of mindfulness meditation: growing insights into neurobiologic aspects of the prevention of depression
Journal of Psychiatry and Neuroscience March 1, 2011 Simon N. Young 23 citations
A recent paper in the Archives of General Psychiatry confirms that mindfulness-based cognitive therapy (MBCT) “offers protection against relapse/recurrence on a par with that of maintenance antidepressant pharmacotherapy.”[1][1] It is a tribute to the accumulated wisdom of humankind that a
Understanding the impact of meditative homework on depression in the context of mindfulness based cognitive therapy (MBCT): An interpretative phenomenological analysis
European Psychiatry March 1, 2011 Helen Murphy, Marika Lahtinen
NICE guidelines indicate one in five people will suffer from depression at some point in their lives with relapse rates of 50–80% in those who have experienced one or more episodes of depression (National Institute for Health and Clinical Excellence [NICE], 2007). By 2020, depression is predicted to be the second largest cause of death or disability and consequently there is a need to explore...
Mindfulness-based cognitive therapy for recurrent depression and anxiety
ANU Open Research 2011 Lauren Clare Wood 1 citation
Mindfulness-based Cognitive Therapy (MBCT) is a class-based manualised program designed to treat recurrent depression and prevent relapse. MBCT has been found to be effective for both symptomatic and asymptomatic patients with three or more previous episodes of depression. While research estimates that 50 - 75% of individuals with depression also experience anxiety, the role of anxiety in the...
Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression.
Addiction Biology 2011
Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression.
Learning Lucid Dreaming and its Effect on Depression in Undergraduates
eCommons 2011 Isaac Yitzhak Taitz 15 citations
The present study tested two hypotheses: 1) that lucid dreaming could be effectively taught through an online intervention, and 2) that lucid dreaming can alleviate depression as mediated by LOC. Surveys consisting of (lucid) dream frequency and recall scales (Schredl & Erlacher, 2004; Doll, Gitter, & Holzinger, 2009), Rotter’s LOC scale (1966), and the most recent Beck Depression Index...
DOI: 10.11588/ijodr.2011.2.9123 (opens in new tab)
Lucid dream
Anxiety
Recall
Intervention counseling
+5